COMPARING EFFICACY OF INTRAVESICAL GEMCITABINE/DOCETAXEL AND BCG IN TREATING VERY HIGH-RISK NON-MUSCLE INVASIVE BLADDER CANCER AS DEFINED BY THE EUROPEAN ASSOCIATION OF UROLOGY (EAU)Mohamad Abou Chakra, Michael J. O’Donnell, Ian M. McElree et al.|Urologic Oncology Seminars and Original Investigations|2025Cited by 0